Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 32 | 2024 | 11695 | 1.810 |
Why?
|
Genome-Wide Association Study | 23 | 2024 | 12220 | 0.890 |
Why?
|
Blood Glucose | 19 | 2023 | 6249 | 0.850 |
Why?
|
Incretins | 1 | 2022 | 88 | 0.810 |
Why?
|
Diabetes Mellitus | 7 | 2023 | 5724 | 0.740 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2020 | 207 | 0.660 |
Why?
|
Mendelian Randomization Analysis | 9 | 2022 | 963 | 0.590 |
Why?
|
Body Mass Index | 8 | 2023 | 12695 | 0.550 |
Why?
|
Coronary Artery Disease | 5 | 2024 | 6454 | 0.550 |
Why?
|
Struma Ovarii | 1 | 2013 | 10 | 0.480 |
Why?
|
Genetic Predisposition to Disease | 14 | 2024 | 17400 | 0.480 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1780 | 0.470 |
Why?
|
Vitamin D-Binding Protein | 1 | 2014 | 129 | 0.460 |
Why?
|
Parenteral Nutrition, Home | 2 | 2023 | 35 | 0.430 |
Why?
|
Cardiovascular Diseases | 5 | 2023 | 15108 | 0.430 |
Why?
|
Obesity | 7 | 2023 | 12705 | 0.420 |
Why?
|
Spouses | 1 | 2014 | 284 | 0.390 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 820 | 0.370 |
Why?
|
Hypoglycemia | 1 | 2015 | 859 | 0.320 |
Why?
|
Polymorphism, Single Nucleotide | 16 | 2023 | 15494 | 0.320 |
Why?
|
Carcinoma, Papillary | 1 | 2013 | 781 | 0.320 |
Why?
|
Fasting | 4 | 2019 | 1589 | 0.300 |
Why?
|
Genetic Variation | 6 | 2023 | 6540 | 0.300 |
Why?
|
Life Style | 2 | 2021 | 3824 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2195 | 0.290 |
Why?
|
Thyroid Nodule | 1 | 2013 | 750 | 0.280 |
Why?
|
Glipizide | 2 | 2023 | 47 | 0.270 |
Why?
|
Neoplasms, Second Primary | 1 | 2013 | 1052 | 0.270 |
Why?
|
Videotape Recording | 1 | 2006 | 350 | 0.260 |
Why?
|
Physicians, Family | 1 | 2006 | 345 | 0.250 |
Why?
|
Insulin Resistance | 5 | 2023 | 3861 | 0.250 |
Why?
|
Risk Factors | 19 | 2023 | 72145 | 0.220 |
Why?
|
Office Visits | 1 | 2006 | 598 | 0.210 |
Why?
|
Scleritis | 1 | 2022 | 100 | 0.200 |
Why?
|
Hyperglycemia | 2 | 2023 | 1368 | 0.200 |
Why?
|
Humans | 58 | 2024 | 742088 | 0.200 |
Why?
|
Multifactorial Inheritance | 3 | 2024 | 1190 | 0.190 |
Why?
|
Stroke | 2 | 2021 | 9963 | 0.180 |
Why?
|
Thyroid Neoplasms | 1 | 2013 | 2274 | 0.180 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2022 | 334 | 0.180 |
Why?
|
Quebec | 3 | 2017 | 133 | 0.180 |
Why?
|
Short Bowel Syndrome | 1 | 2023 | 345 | 0.180 |
Why?
|
Insulin | 5 | 2022 | 6575 | 0.170 |
Why?
|
Metabolomics | 2 | 2018 | 1467 | 0.170 |
Why?
|
Genes, Recessive | 1 | 2022 | 642 | 0.170 |
Why?
|
Carbohydrate Metabolism | 1 | 2020 | 264 | 0.170 |
Why?
|
Focus Groups | 2 | 2014 | 1320 | 0.170 |
Why?
|
Uveitis | 1 | 2022 | 375 | 0.170 |
Why?
|
Williams Syndrome | 1 | 2021 | 187 | 0.170 |
Why?
|
Meta-Analysis as Topic | 2 | 2021 | 1342 | 0.160 |
Why?
|
Hyperuricemia | 1 | 2021 | 208 | 0.160 |
Why?
|
Glucose | 4 | 2023 | 4391 | 0.160 |
Why?
|
Hemoglobin, Sickle | 1 | 2019 | 122 | 0.160 |
Why?
|
Population Groups | 1 | 2019 | 208 | 0.160 |
Why?
|
Quantitative Trait, Heritable | 1 | 2021 | 544 | 0.160 |
Why?
|
Prediabetic State | 1 | 2023 | 493 | 0.160 |
Why?
|
Sarcopenia | 1 | 2022 | 368 | 0.150 |
Why?
|
Diabetes Complications | 2 | 2016 | 1359 | 0.150 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4823 | 0.140 |
Why?
|
Diabetes, Gestational | 3 | 2020 | 1184 | 0.140 |
Why?
|
Causality | 2 | 2021 | 1265 | 0.140 |
Why?
|
Chromosomes, Human, X | 1 | 2018 | 296 | 0.140 |
Why?
|
Metformin | 1 | 2023 | 829 | 0.140 |
Why?
|
Adult | 17 | 2023 | 213712 | 0.140 |
Why?
|
Uric Acid | 1 | 2021 | 760 | 0.130 |
Why?
|
Disease | 1 | 2021 | 681 | 0.130 |
Why?
|
Chemokines, CC | 1 | 2016 | 291 | 0.130 |
Why?
|
Odds Ratio | 5 | 2020 | 9846 | 0.130 |
Why?
|
Femur Neck | 1 | 2017 | 309 | 0.130 |
Why?
|
Body Composition | 2 | 2022 | 2400 | 0.130 |
Why?
|
Alleles | 4 | 2022 | 6931 | 0.130 |
Why?
|
Education, Medical | 1 | 2006 | 1717 | 0.120 |
Why?
|
Bayes Theorem | 2 | 2022 | 2303 | 0.120 |
Why?
|
Male | 23 | 2023 | 349538 | 0.120 |
Why?
|
Glucose Intolerance | 2 | 2020 | 577 | 0.120 |
Why?
|
Middle Aged | 16 | 2023 | 213127 | 0.120 |
Why?
|
Keratin-19 | 1 | 2013 | 33 | 0.120 |
Why?
|
Triglycerides | 2 | 2022 | 2450 | 0.120 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2354 | 0.120 |
Why?
|
Female | 25 | 2023 | 379592 | 0.120 |
Why?
|
Postpartum Period | 1 | 2020 | 1078 | 0.120 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 3239 | 0.110 |
Why?
|
Child Care | 1 | 2014 | 119 | 0.110 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 997 | 0.110 |
Why?
|
Case-Control Studies | 4 | 2022 | 21719 | 0.110 |
Why?
|
Insurance Claim Review | 1 | 2017 | 720 | 0.110 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 65 | 0.100 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7770 | 0.100 |
Why?
|
Genome, Human | 2 | 2021 | 4420 | 0.100 |
Why?
|
Prevalence | 3 | 2022 | 15194 | 0.090 |
Why?
|
Databases, Factual | 2 | 2017 | 7716 | 0.090 |
Why?
|
Iodine Radioisotopes | 1 | 2013 | 1030 | 0.090 |
Why?
|
Coronary Disease | 2 | 2015 | 6078 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 1434 | 0.090 |
Why?
|
Proteomics | 1 | 2022 | 3618 | 0.080 |
Why?
|
Gene Frequency | 3 | 2022 | 3587 | 0.080 |
Why?
|
Cholesterol | 1 | 2017 | 2895 | 0.080 |
Why?
|
Erythrocytes | 1 | 2018 | 2452 | 0.080 |
Why?
|
Dyslipidemias | 1 | 2015 | 848 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2013 | 1769 | 0.080 |
Why?
|
Tumor Burden | 1 | 2013 | 1905 | 0.080 |
Why?
|
Hypolipidemic Agents | 1 | 2012 | 604 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13256 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 1 | 2013 | 1204 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2020 | 3679 | 0.070 |
Why?
|
Neoplasms | 1 | 2016 | 21596 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2017 | 39004 | 0.070 |
Why?
|
Cohort Studies | 4 | 2020 | 40450 | 0.070 |
Why?
|
Genetic Loci | 3 | 2022 | 2572 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3920 | 0.070 |
Why?
|
Vitamin D | 2 | 2022 | 3211 | 0.070 |
Why?
|
Hypoglycemic Agents | 2 | 2023 | 2866 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1331 | 0.070 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2906 | 0.070 |
Why?
|
Genotype | 4 | 2023 | 12946 | 0.070 |
Why?
|
Logistic Models | 2 | 2020 | 13403 | 0.060 |
Why?
|
Hypertension | 2 | 2015 | 8455 | 0.060 |
Why?
|
Prospective Studies | 5 | 2022 | 53187 | 0.060 |
Why?
|
Internet | 2 | 2014 | 3062 | 0.060 |
Why?
|
Glucose Tolerance Test | 2 | 2020 | 1150 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2012 | 827 | 0.060 |
Why?
|
Weight Gain | 1 | 2014 | 2282 | 0.060 |
Why?
|
Patient Simulation | 1 | 2006 | 308 | 0.060 |
Why?
|
Islets of Langerhans | 2 | 2024 | 1351 | 0.060 |
Why?
|
Computers | 1 | 2006 | 611 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2020 | 13921 | 0.060 |
Why?
|
Bone Density | 1 | 2017 | 3469 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2013 | 2658 | 0.060 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 65 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2014 | 2117 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15530 | 0.060 |
Why?
|
Europe | 2 | 2022 | 3339 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8626 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 24913 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8541 | 0.050 |
Why?
|
Physical Chromosome Mapping | 1 | 2021 | 183 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3691 | 0.050 |
Why?
|
Aged | 6 | 2021 | 162944 | 0.050 |
Why?
|
Quantitative Trait Loci | 2 | 2021 | 2015 | 0.050 |
Why?
|
Body Fat Distribution | 1 | 2022 | 244 | 0.050 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3076 | 0.050 |
Why?
|
Primary Health Care | 1 | 2015 | 4551 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11001 | 0.040 |
Why?
|
Risk Assessment | 2 | 2017 | 23320 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3915 | 0.040 |
Why?
|
Epigenomics | 1 | 2024 | 902 | 0.040 |
Why?
|
Taurine | 1 | 2018 | 94 | 0.040 |
Why?
|
Homozygote | 1 | 2022 | 1777 | 0.040 |
Why?
|
Sleep | 2 | 2023 | 4604 | 0.040 |
Why?
|
Adipocytes | 1 | 2024 | 1182 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2024 | 983 | 0.040 |
Why?
|
Pilot Projects | 2 | 2023 | 8297 | 0.040 |
Why?
|
Phenylalanine | 1 | 2018 | 365 | 0.040 |
Why?
|
Absorptiometry, Photon | 1 | 2022 | 1726 | 0.040 |
Why?
|
Nutrition Surveys | 1 | 2022 | 1656 | 0.030 |
Why?
|
Metabolome | 1 | 2022 | 881 | 0.030 |
Why?
|
Glucose-6-Phosphatase | 1 | 2015 | 73 | 0.030 |
Why?
|
Gout | 1 | 2021 | 556 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23387 | 0.030 |
Why?
|
Glycine | 1 | 2018 | 671 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2781 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2935 | 0.030 |
Why?
|
Glycemic Index | 1 | 2017 | 395 | 0.030 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2016 | 563 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1608 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1653 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2016 | 527 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57683 | 0.030 |
Why?
|
Introns | 1 | 2016 | 991 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2183 | 0.030 |
Why?
|
Peripheral Arterial Disease | 1 | 2024 | 1184 | 0.030 |
Why?
|
United States | 2 | 2022 | 69693 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2014 | 15244 | 0.030 |
Why?
|
Chromatin | 1 | 2024 | 2917 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2018 | 1157 | 0.030 |
Why?
|
Phenotype | 2 | 2021 | 16331 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2023 | 3611 | 0.020 |
Why?
|
Gestational Age | 1 | 2020 | 3490 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3455 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2015 | 1995 | 0.020 |
Why?
|
Pregnancy | 3 | 2020 | 29087 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3528 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 2018 | 1205 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1337 | 0.020 |
Why?
|
Weight Loss | 1 | 2021 | 2604 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2566 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1707 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 20928 | 0.020 |
Why?
|
Sex Factors | 1 | 2022 | 10392 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3639 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3493 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8662 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 62966 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2022 | 4933 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9387 | 0.020 |
Why?
|
Young Adult | 2 | 2022 | 56350 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10372 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3518 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2699 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9679 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9410 | 0.020 |
Why?
|
Qualitative Research | 1 | 2013 | 2680 | 0.020 |
Why?
|
Exercise | 1 | 2021 | 5611 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18355 | 0.010 |
Why?
|
Body Weight | 1 | 2014 | 4664 | 0.010 |
Why?
|
Social Support | 1 | 2013 | 2117 | 0.010 |
Why?
|
Prognosis | 1 | 2023 | 29010 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12344 | 0.010 |
Why?
|
Genomics | 1 | 2017 | 5692 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2013 | 3187 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12730 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19862 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29717 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12164 | 0.010 |
Why?
|
Diet | 1 | 2013 | 7923 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40054 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 40955 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2014 | 77098 | 0.000 |
Why?
|
Concepts
(219)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(81)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_